Anticoagulation for Upper Extremity Orthopedic Surgery

Risk Assessment and Guidelines

The American College of Chest Physicians (ACCP) guidelines focus primarily on major orthopedic surgeries of the lower extremity, and upper extremity orthopedic procedures are not specifically classified as "major orthopedic surgery" requiring routine prophylaxis 1, 2, 3.
Risk stratification should be performed using validated tools such as the Caprini score, which considers both patient-specific and procedure-specific factors 4.

Patients with a previous history of VTE, active cancer, or known thrombophilia may require anticoagulation 1, 4, 5.
Patients with multiple risk factors that would place them in a high-risk category (Caprini score ≥5) may also require anticoagulation 4.

For patients with additional VTE risk factors, consider mechanical prophylaxis with intermittent pneumatic compression devices (IPCD) during surgery and early post-operative period 1, 3.
For high-risk patients, consider pharmacologic prophylaxis with LMWH, with or without mechanical methods 4.
If anticoagulation is deemed necessary, LMWH is suggested as the preferred agent, with alternative options including direct oral anticoagulants (apixaban, dabigatran, rivaroxaban) if compliance with injections is a concern 1, 2, 6.

If a patient requiring prophylaxis has increased bleeding risk, mechanical prophylaxis with IPCD should be used instead of pharmacologic agents until bleeding risk decreases 1, 7.
Mechanical prophylaxis achieves 18 hours of daily compliance when possible 1, 3.

Overprescribing anticoagulation for low-risk upper extremity procedures increases bleeding risk without significant benefit 7.
Failing to identify patients with multiple risk factors who might benefit from prophylaxis despite undergoing upper extremity surgery 4.
Not considering patient compliance with injectable medications if prophylaxis is prescribed for outpatient use 1, 6.